Clinical trials recruiting for Unresectable Solid Tumor
5
Recruiting trials
25
US states with sites
9
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 1 5Phase 2 2
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| CLSP-1025 | 1 |
| FMC-376 | 1 |
| Fulvestrant | 1 |
| MDNA11 | 1 |
| PF-07220060 100mg | 1 |
| PF-07220060 300 mg | 1 |
| Palbociclib 125mg | 1 |
| Pembrolizumab (KEYTRUDA®) | 1 |
| RGT-490 | 1 |
| RLY-2608 | 1 |
| Ribociclib 400mg | 1 |
| Ribociclib 600mg | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 5 |
| Texas | 5 |
| Florida | 4 |
| Michigan | 3 |
| Virginia | 3 |
| Arizona | 2 |
| Illinois | 2 |
| Indiana | 2 |
| Massachusetts | 2 |
| New Jersey | 2 |
| New York | 2 |
| Pennsylvania | 2 |
Top cities
Houston, Texas 5Fairfax, Virginia 3San Francisco, California 3Boston, Massachusetts 2Chicago, Illinois 2Dallas, Texas 2Detroit, Michigan 2Los Angeles, California 2Nashville, Tennessee 2New York, New York 2
Self-screener
Recruiting trials
- A Beta-only IL-2 ImmunoTherapY Study
- A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
- First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
- Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
Related conditions
Trials recruiting for Unresectable Solid Tumor often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239Solid Tumor, Adult 38Pancreatic cancer 870Ovarian cancer 118Lung cancer 2180PIK3CA Mutation 3Metastatic Solid Tumor 22HER2- Negative Breast Cancer 57Endometrial cancer 68Colorectal cancer 1359
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Unresectable Solid Tumor trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.